ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,07711
0,01%
Bitcoin
61.298,95
-0,24%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. AbCellera Biologics Inc (ABCL)

  7. AbCellera Biologics Inc (ABCL) News

ABCL

AbCellera Biologics (ABCL)

AbCellera Biologics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ABCL
DatumZeitQuelleÜberschriftSymbolFirma
07/05/202422h47Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABCLAbCellera Biologics Inc
07/05/202422h22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
07/05/202422h05Business WireAbCellera Reports Q1 2024 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
01/05/202415h00Business WireAbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech CompaniesNASDAQ:ABCLAbCellera Biologics Inc
08/04/202418h05Business WireAbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024NASDAQ:ABCLAbCellera Biologics Inc
03/04/202422h05Business WireAbCellera to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:ABCLAbCellera Biologics Inc
19/03/202421h05Business WireAbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024NASDAQ:ABCLAbCellera Biologics Inc
11/03/202414h00Business WireAbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological ConditionsNASDAQ:ABCLAbCellera Biologics Inc
05/03/202422h30Business WireAbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024NASDAQ:ABCLAbCellera Biologics Inc
27/02/202420h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
23/02/202422h49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
23/02/202422h30Business WireAbCellera Announces Resignation of Board MemberNASDAQ:ABCLAbCellera Biologics Inc
23/02/202402h15Business WireAbCellera to Present at Upcoming Investor Conferences in MarchNASDAQ:ABCLAbCellera Biologics Inc
20/02/202422h49Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ABCLAbCellera Biologics Inc
20/02/202422h27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
20/02/202422h05Business WireAbCellera Reports Full Year 2023 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
23/01/202422h05Business WireAbCellera to Report Full Year 2023 Financial Results on February 20, 2024NASDAQ:ABCLAbCellera Biologics Inc
17/01/202400h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
17/01/202400h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
17/01/202400h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
17/01/202400h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
20/12/202322h05Business WireAbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024NASDAQ:ABCLAbCellera Biologics Inc
20/12/202300h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
28/11/202323h28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
27/11/202322h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
16/11/202322h05Business WireAbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023NASDAQ:ABCLAbCellera Biologics Inc
08/11/202321h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
08/11/202321h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
08/11/202321h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
03/11/202317h05Business WireAbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023NASDAQ:ABCLAbCellera Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:ABCL

Kürzlich von Ihnen besucht

DGFX
FUNDETH
Unification
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten